Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-25

FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) from Mainpointe Pharmaceuticals. The approval indicates a c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TUXARIN (Codeine phosphate and chlorpheniramine maleate)

Snippet

SUPPL AP for TUXARIN (CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE)